Pfizer Global Research and Development, La Jolla Laboratories, 10646 Science Center Drive, San Diego, CA 92121, USA.
J Chromatogr A. 2010 Sep 24;1217(39):6110-4. doi: 10.1016/j.chroma.2010.07.066. Epub 2010 Aug 3.
Medicinal chemists often depend on analytical instrumentation for reaction monitoring and product confirmation at all stages of pharmaceutical discovery and development. To obtain pure compounds for biological assays, the removal of side products and final compounds through purification is often necessary. Prior to purification, chemists often utilize open-access analytical LC/MS instruments because mass confirmation is fast and reliable, and the chromatographic separation of most sample constituents is sufficient. Supercritical fluid chromatography (SFC) is often used as an orthogonal technique to HPLC or when isolation of the free base of a compound is desired. In laboratories where SFC is the predominant technique for analysis and purification of compounds, a reasonable approach for quickly determining suitable purification conditions is to screen the sample against different columns. This can be a bottleneck to the purification process. To commission SFC for open-access use, a walk-up analytical SFC/MS screening system was implemented in the medicinal chemistry laboratory. Each sample is automatically screened through six column/method conditions, and on-demand data processing occurs for the chromatographers after each screening method is complete. This paper highlights the "FastTrack" approach to expediting samples through purification.
药物化学家在药物发现和开发的各个阶段经常依赖分析仪器来进行反应监测和产物确认。为了获得用于生物测定的纯化合物,通常需要通过纯化去除副产物和最终化合物。在纯化之前,化学家通常使用开放访问的分析 LC/MS 仪器,因为质量确认快速可靠,并且大多数样品成分的色谱分离已经足够。超临界流体色谱 (SFC) 通常用作 HPLC 的正交技术,或者当需要分离化合物的游离碱时。在以 SFC 为主要分析和化合物纯化技术的实验室中,快速确定合适的纯化条件的合理方法是针对不同的柱子筛选样品。这可能是纯化过程的瓶颈。为了将 SFC 投入开放使用,在药物化学实验室中实施了一种可随时使用的分析 SFC/MS 筛选系统。每个样品通过六种柱/方法条件自动进行筛选,并且在每次筛选方法完成后,为色谱师按需进行数据处理。本文重点介绍了“快速通道”方法,以加快样品的纯化过程。